Home News Thomas Flaig, MD, on Novel Combination Therapy for Advanced Urothelial Cancer back to News
In the following interview, co-author Thomas Flaig, vice chancellor for research for the University of Colorado Denver and the Anschutz Medical Campus in Aurora, discussed details of the study and the drug combination.
Topics: Press Coverage
12631 East 17th Avenue
8601
Aurora, CO 80045
303-724-1785
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
